Home » Topics » Conferences

Conferences
RSS

Fujsawa selects adenosine A1 receptor antagonist for development

April 11, 1997

MDR-reversing agents described by Nikken Chemicals

April 11, 1997

New LTD4 antagonist from Fujisawa

April 10, 1997

New carbamate derivative from Kyorin with high affinity/selectivity for M1 receptors

April 10, 1997

Senju describes new calpain inhibitor

April 10, 1997

FR-138104: a new D2 antagonist from Fujisawa

April 10, 1997

New bradykinin B2 antagonist from Fujisawa

April 10, 1997

Nigella sativa plant extract exerts antiangiogenic activity

April 8, 1997

PEG-rHuMGDF safe and effective for chemotherapy-induced thrombocytopenia

April 8, 1997

Perindopril accelerates endothelial regrowth in animal model

April 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.